Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell S Finkel

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Postgraduate Medicine|August 12, 2009
Molecular signaling pathways that link depression and heart diseaseMitchell S Finkel
Critical Care Medicine|March 21, 2002
Source of inflammatory mediators in cardiopulmonary bypassMitchell S Finkel
Journal of Cellular Physiology|February 25, 2003
Inflammatory mediators and reversible myocardial dysfunctionHong Kan, Mitchell S Finkel
Cardiovascular Toxicology|August 1, 2009
p38 MAP kinase inhibitor prevents diastolic dysfunction in rats following HIV gp120 injection in vivoChalak Berzingi, Fangping Chen, Mitchell S Finkel
American Journal of Physiology. Cell Physiology|December 9, 2003
p38 MAP kinase-mediated negative inotropic effect of HIV gp120 on cardiac myocytesHong Kan, Zirong Xie, Mitchell S Finkel
Critical Care Medicine|January 21, 2011
The Frog Prince of calcium homeostasisSarah Hadique, Chet Khamare, Mitchell S Finkel
AIDS (London, England)|April 13, 2012
Diastolic dysfunction following HIV infectionFangping Chen, Ravindra Bhardwaj, Mitchell S Finkel
Journal of Molecular and Cellular Cardiology|December 1, 2005
iPLA2 inhibitor blocks negative inotropic effect of HIV gp120 on cardiac myocytesHong Kan, Zirong Xie, Mitchell S Finkel
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 14, 2009
p38 MAP kinase inhibitor reverses stress-induced myocardial dysfunction in vivoFangping Chen, Hong Kan, Gerry Hobbs, et al.
Critical Care Medicine|December 15, 2005
Reversible myocardial dysfunction in sepsis and ischemiaHong Kan, Conard F Failinger, Qiujuan Fang, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Postgraduate Medicine|August 12, 2009
Molecular signaling pathways that link depression and heart diseaseMitchell S Finkel
Critical Care Medicine|March 21, 2002
Source of inflammatory mediators in cardiopulmonary bypassMitchell S Finkel
Journal of Cellular Physiology|February 25, 2003
Inflammatory mediators and reversible myocardial dysfunctionHong Kan, Mitchell S Finkel
Cardiovascular Toxicology|August 1, 2009
p38 MAP kinase inhibitor prevents diastolic dysfunction in rats following HIV gp120 injection in vivoChalak Berzingi, Fangping Chen, Mitchell S Finkel
American Journal of Physiology. Cell Physiology|December 9, 2003
p38 MAP kinase-mediated negative inotropic effect of HIV gp120 on cardiac myocytesHong Kan, Zirong Xie, Mitchell S Finkel
Critical Care Medicine|January 21, 2011
The Frog Prince of calcium homeostasisSarah Hadique, Chet Khamare, Mitchell S Finkel
AIDS (London, England)|April 13, 2012
Diastolic dysfunction following HIV infectionFangping Chen, Ravindra Bhardwaj, Mitchell S Finkel
Journal of Molecular and Cellular Cardiology|December 1, 2005
iPLA2 inhibitor blocks negative inotropic effect of HIV gp120 on cardiac myocytesHong Kan, Zirong Xie, Mitchell S Finkel
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 14, 2009
p38 MAP kinase inhibitor reverses stress-induced myocardial dysfunction in vivoFangping Chen, Hong Kan, Gerry Hobbs, et al.
Critical Care Medicine|December 15, 2005
Reversible myocardial dysfunction in sepsis and ischemiaHong Kan, Conard F Failinger, Qiujuan Fang, et al.
Pageof 3